We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmakers Debate Import Safety, How to Stop Counterfeit Drugs
Lawmakers Debate Import Safety, How to Stop Counterfeit Drugs
October 1, 2007
The FDA needs to increase inspections and ensure the safety of imported products over their life cycles to prevent counterfeit and substandard drugs from entering the U.S. drug supply chain, witnesses and lawmakers said during a House Subcommittee on Health hearing last month.